As of June 3, 2021, Libya had registered almost 190,000 positive COVID 19 cases and more than 3,000 COVID-19-related deaths. The average of daily new infections was around 300 in early June, down from a peak of around 1,000 in early April. The true spread of the disease in Libya is likely to be higher because of restricted access to testing across the country (the positivity rate was 12 percent in May), as well as limitations in data compilation. In December 2020, the government reported that Libya had signed a contract with the World Health Organization (WHO) for the purchase of 2.8 million doses of the AstraZeneca COVID-19 vaccine at a cost of about to US$9.4 million. Media reports suggest that Libya has so far received 200,000 doses of Russia's Sputnik V vaccine and more than 57,000 AstraZeneca shots through the WHO. The WHO reports that around 240,000 vaccine doses had been administered in the country as of June 1.
Key Policy Responses as of June 3, 2021
Fiscal. In the spring of 2020, the Government of National Accord (GNA) announced a package of USD100 million(about 1 percent of GDP) in emergency COVID-19 related spending. In early January 2021, the Central Bank of Libya stated that the total amount of funds spent to combat the pandemic had reached about USD 290million (more than 2 percent of GDP).Medical equipment is in short supply due to the pandemic and the civil war. To protect declining reserves, the GNA announced a 20 percent pay cut for civil servants in April 2020.
Civic Freedom Tracker
GOVERNMENT OF NATIONAL ACCORD (GNA) PRESIDENTIAL COUNCIL RESOLUTION OF NO. 277 OF 2020
Libya's UN-backed government imposes a lockdown and a ban on individual movement for 10 days starting from April 17, 2020, with limited exceptions for the transport and sale of food. Moving on foot is allowed between 7am and 12pm only. (See primary source or citation here)
Date Introduced: 17 Apr 2020